MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes

Phase 2
Completed
Conditions
Type 2 Diabetes
Vitamin D Insufficiency
Interventions
First Posted Date
2008-12-22
Last Posted Date
2010-07-12
Lead Sponsor
University of Aarhus
Target Recruit Count
16
Registration Number
NCT00812578
Locations
🇩🇰

Medical Research Unit, Medical Department M, Aarhus University Hospital, Aarhus, Denmark

Vitamin D AND Glucose Handling Evaluated by Glucose Clamp

Phase 2
Completed
Conditions
Insulin Sensitivity
Intraocular Pressure
First Posted Date
2008-12-17
Last Posted Date
2011-11-03
Lead Sponsor
University Hospital of North Norway
Target Recruit Count
160
Registration Number
NCT00809744
Locations
🇳🇴

University Hospital of North Norway, Tromsø, Norway

Vitamin D Treatment in Patients With Chronic Hepatitis C

Not Applicable
Conditions
Chronic Hepatitis C
Interventions
Drug: Adding vitamin D
Drug: Vitamin D
First Posted Date
2008-12-09
Last Posted Date
2008-12-09
Lead Sponsor
Hillel Yaffe Medical Center
Registration Number
NCT00804752
Locations
🇮🇱

Hillel Yaffe Medical Center, Hadera, Israel

20070360 Incident Dialysis

Phase 4
Completed
Conditions
Secondary Hyperparathyroidism
Chronic Kidney Disease
Interventions
First Posted Date
2008-12-05
Last Posted Date
2018-10-17
Lead Sponsor
Amgen
Target Recruit Count
313
Registration Number
NCT00803712

Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

Phase 2
Completed
Conditions
Psoriasis
Atopic Dermatitis
Interventions
Drug: Placebo
Drug: Vitamin D3
First Posted Date
2008-11-13
Last Posted Date
2017-04-12
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
82
Registration Number
NCT00789880
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

🇺🇸

University of California, San Diego, San Diego, California, United States

🇺🇸

National Jewish Health, Denver, Colorado, United States

Vitamin D in Active Tuberculosis (TB) Study

Not Applicable
Withdrawn
Conditions
Tuberculosis
Interventions
Drug: Placebo
Drug: Vitamin D3
First Posted Date
2008-11-10
Last Posted Date
2012-01-20
Lead Sponsor
Atlanta VA Medical Center
Registration Number
NCT00788320
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model

Early Phase 1
Completed
Conditions
Gingivitis
Interventions
Other: Placebo
Drug: vitamin D3
First Posted Date
2008-10-24
Last Posted Date
2017-10-02
Lead Sponsor
Boston University
Target Recruit Count
35
Registration Number
NCT00779909
Locations
🇺🇸

Boston University Goldman School of Dental Medicine, Boston, Massachusetts, United States

Vitamin D Repletion in Chronic Kidney Disease

Early Phase 1
Completed
Conditions
Chronic Kidney Disease
Interventions
First Posted Date
2008-10-15
Last Posted Date
2015-01-15
Lead Sponsor
Rockefeller University
Target Recruit Count
12
Registration Number
NCT00772772
Locations
🇺🇸

Rockefeller University, New York, New York, United States

Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients

Phase 3
Conditions
Kidney Transplantation
Vitamin D Deficiency
Renal Osteodystrophy
Interventions
First Posted Date
2008-09-15
Last Posted Date
2014-01-22
Lead Sponsor
Medical University of Vienna
Target Recruit Count
200
Registration Number
NCT00752401
Locations
🇦🇹

Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis, Vienna, Austria

Vitamin D, Insulin Resistance, and Cardiovascular Disease

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Hypertension
Insulin Resistance
Type 2 Diabetes Mellitus
Cardiovascular Disease
Interventions
Drug: Placebo
Drug: Vitamin D3
First Posted Date
2008-08-18
Last Posted Date
2020-02-10
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
125
Registration Number
NCT00736632
Locations
🇺🇸

Washington Universiy, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath